Context Therapeutics Inc (CNTX) EPS is poised to hit -0.06 next quarter: How Investors Can Make It Count the Most?
Context Therapeutics Inc (NASDAQ: CNTX) open the trading on Thursday, with a bit cautious approach as it glided -7.98% to $1.50, before settling in for